354 related articles for article (PubMed ID: 8907904)
1. Impact of natural killer cells in mediating graft-versus-host disease following small bowel transplantation in a rat model.
Fändrich F; Exner B; Papachrysanthou A; Jahnke T; Chambers WH; Zavazava N
Transplant Proc; 1996 Oct; 28(5):2465-6. PubMed ID: 8907904
[No Abstract] [Full Text] [Related]
2. Role of donor natural killer cells on lethal graft-versus-host disease following small bowel transplantation in the rat.
Okamoto M; Arakawa K; Akioka K; Fujiwara I; Takeshita K; Oka T
Transplant Proc; 1996 Oct; 28(5):2467-8. PubMed ID: 8907905
[No Abstract] [Full Text] [Related]
3. Modulation of graft-vs-host-related disease by host-specific natural killer cell activity following semiallogeneic small bowel transplantation in the rat.
Fändrich F; Schröder J; Jahnke T; Dresske B; Chambers WH; Zavazava N
Transplant Proc; 1996 Dec; 28(6):3267-8. PubMed ID: 8962268
[No Abstract] [Full Text] [Related]
4. NK activity during graft-vs-host disease and graft rejection in rats following intestinal transplantation.
Frezza EE; Gerunda GE; Fassina A; DeFranchis R; Biffi R; Gurakar A; Fagiuoli S; Maffei FA; Van Thiel DH
Transplant Proc; 1994 Jun; 26(3):1626. PubMed ID: 8030063
[No Abstract] [Full Text] [Related]
5. Characterisation of blood lymphocyte subsets following rat small bowel transplantation.
Webster GA; Bowles MJ; Karim MS; Wood RF; Pockley AG
Transplant Proc; 1994 Jun; 26(3):1554. PubMed ID: 8030032
[No Abstract] [Full Text] [Related]
6. CD8+ host cells infiltrate the intestinal mucosa after allogeneic small bowel transplantation even in the absence of acute rejection.
Nüssler NC; Cicalese L; Hoffman RA; Rastellini C; Neuhaus P; Simmons RL; Schraut WH
Transplant Proc; 1996 Oct; 28(5):2456. PubMed ID: 8907898
[No Abstract] [Full Text] [Related]
7. Anti-graft and anti-host antibody responses following small bowel transplantation in the rat.
Bowles MJ; Wood RF; Pockley AG
Transplant Proc; 1996 Oct; 28(5):2486. PubMed ID: 8907916
[No Abstract] [Full Text] [Related]
8. Mesenteric and intraepithelial lymphocytes are insufficient to cause rejection but able to mediate lethal graft-versus-host disease in small bowel transplants.
Xia W; Brandeis JM; Sayegh M; Kirkman RL
Transplant Proc; 1994 Jun; 26(3):1508-9. PubMed ID: 8030013
[No Abstract] [Full Text] [Related]
9. Donor intrathymic injection with recipient splenocytes allows indefinite survival following small bowel transplantation in a rat graft-vs-host disease model.
Blakely ML; Shaffer D; Ohzato H; Gottschalk R; Van der Werf WJ; Monaco AP
Transplant Proc; 1994 Jun; 26(3):1582. PubMed ID: 8030046
[No Abstract] [Full Text] [Related]
10. Correlation between changes in cellular immunity and rejection in rat small bowel transplantation.
Wang P; Zhu L; Liu T; He X; Zhu W
Transplant Proc; 1994 Jun; 26(3):1557. PubMed ID: 7913267
[No Abstract] [Full Text] [Related]
11. Efficacy of a new immunosuppressant, CAM, on small bowel transplantation in rats.
Sawada H; Kaihara S; Egawa H; Inomata Y; Tanaka K; Yamaoka Y
Transplant Proc; 1996 Oct; 28(5):2512-3. PubMed ID: 8907928
[No Abstract] [Full Text] [Related]
12. Portal venous drainage is not beneficial in multivisceral small bowel allografts.
D'Silva M; Candinas D; Hubscher SG; McMaster P
Transplant Proc; 1996 Oct; 28(5):2475-6. PubMed ID: 8907910
[No Abstract] [Full Text] [Related]
13. The effect of rapamycin on orthotopic small bowel transplantation in the rat.
Chen H; Wu J; Xu D; Aboujaoude M; Stepkowski S; Kahan B; Daloze P
Transplant Proc; 1992 Jun; 24(3):1157-8. PubMed ID: 1604567
[No Abstract] [Full Text] [Related]
14. NK activity during graft-versus-host disease and graft rejection in rats following intestinal semiallogenic and allogenic transplantation with or without mesenteric lymphadenectomy.
Frezza EE; Gerunda GE; Fassina A; DeFranchis R; Biffi R; Gurakar A; Fagiuoli S; Faccioli AM; Van Thiel DH
Transplantation; 1994 Sep; 58(6):698-701. PubMed ID: 7940689
[TBL] [Abstract][Full Text] [Related]
15. Leflunomide immunosuppression in rat small intestinal transplantation.
Foster PF; Xiao F; Kociss K; Chong AS; Sankary HN; McChesney L; Cohn S; Williams JW
Transplant Proc; 1994 Jun; 26(3):1599-600. PubMed ID: 8030053
[No Abstract] [Full Text] [Related]
16. Importance of lymphoid tissue for survival of small bowel allografts.
Pirenne J; Williams JG; Kim S; Fryer J; Benedetti E; Hakim NS; Médot M; Najarian JS; Gruessner RW; Dunn DL
Transplant Proc; 1995 Feb; 27(1):1359-60. PubMed ID: 7878911
[No Abstract] [Full Text] [Related]
17. Impact of natural killer cells and macrophages on the course of acute graft rejection following allogeneic heart transplantation in the rat.
Dresske B; Zhu X; Peters J; Brötzmann K; Fändrich F
Transplant Proc; 1996 Dec; 28(6):3259-60. PubMed ID: 8962264
[No Abstract] [Full Text] [Related]
18. Donor pretreatment with monoclonal antibody for prevention of graft-versus-host disease following small bowel transplantation: effect of depletion of T-cell subsets.
Shaffer D; Simpson MA; Milford EL; Gottschalk R; Kut JP; Maki T; Monaco AP
Transplant Proc; 1991 Feb; 23(1 Pt 1):679-81. PubMed ID: 1990646
[No Abstract] [Full Text] [Related]
19. Effect of donor pretreatment on graft-versus-host disease (GVHD) after rat small-bowel transplantation (SBTX).
Matsumoto S; Tanaka S; Orita K
Transplant Proc; 1994 Aug; 26(4):2306-8. PubMed ID: 8066758
[No Abstract] [Full Text] [Related]
20. Host vs graft and graft vs host reactions after allogeneic heterotopic small bowel transplantation in the rat.
Gasser M; Prange K; Schroeder P; Stoffregen C; Eckstein V; Deltz E
Transplant Proc; 1992 Jun; 24(3):1128-9. PubMed ID: 1604550
[No Abstract] [Full Text] [Related]
[Next] [New Search]
